All In MedTech

Device Trial Radar · NCT00715026

Trilogy AB Acetabular Hip System Post Approval Study

Multicenter Post Approval Study of the Trilogy AB(R) Acetabular System

Last checked: Nov 20, 2026Latest source record: Nov 26, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

31

Actual

Start

Apr 2009

Primary completion

Jun 2012

Study completion Jun 2012

Sponsor

Lead sponsor
Zimmer BiometPublic (ZBH)
Sponsor type
Industry
First posted
Jul 15, 2008

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a post-approval study with prospective enrollment in the United States and a retrospective enrollment outside the United States to obtain functional, quality of life and radiographic data, which will facilitate assessment of the clinical performance of the Zimmer Trilogy AB Acetabular Hip System.

Conditions

  • Osteoarthritis
  • Avascular Necrosis
  • Congenital Hip Dysplasia
  • Traumatic Arthritis

Interventions

  • Trilogy AB Acetabular Hip Implant SystemDevice

    Total hip replacement with ceramic on ceramic treatment surfaces.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Harris Hip ScoreTime frame: Pre-op, 3 Month Post-Op and Annual Post-Op visits through 5 Years

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Shrock Orthopedic Research

    Fort Lauderdale, Florida

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.